Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -17.13% is 513% below its 5-year average of -2.79%, around the middle of its 5-year range (-51.23%–32.41%).
As of the fiscal period ended Tuesday, June 30, 2026. 48.33% below its 12-month average of -11.55%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
-17.13%
RETURN ON EQUITY (ROE) AVG TTM
-11.55%
RETURN ON EQUITY (ROE) AVG 3Y
0.28%
RETURN ON EQUITY (ROE) AVG 5Y
-2.79%
RETURN ON EQUITY (ROE) AVG 10Y
10.37%
RETURN ON EQUITY (ROE) AVG 15Y
19.40%
RETURN ON EQUITY (ROE) AVG 20Y
21.18%
CURRENT VS TTM AVG
-48.33%
CURRENT VS 3Y AVG
-6303.47%
CURRENT VS 5Y AVG
-513.21%
CURRENT VS 10Y AVG
-265.19%
CURRENT VS 15Y AVG
-188.31%
CURRENT VS 20Y AVG
-180.87%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-231.66%
vs the sector median at left
Baxter International Inc.
Market Cap
$12.76B
Return on Equity (ROE)
-17.13%
TTM Avg
-11.55%
3Y Avg
0.28%
5Y Avg
-2.79%
Market Cap
$12.61B
Return on Equity (ROE)
2.86%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
Market Cap
$12.60B
Return on Equity (ROE)
10.49%
TTM Avg
6.83%
3Y Avg
5.29%
5Y Avg
3.21%
Market Cap
$13.34B
Return on Equity (ROE)
-8.40%
TTM Avg
-2.13%
3Y Avg
6.32%
5Y Avg
9.65%
Market Cap
$12.02B
Return on Equity (ROE)
23.91%
TTM Avg
22.63%
3Y Avg
21.83%
5Y Avg
21.13%
Market Cap
$11.80B
Return on Equity (ROE)
N/A
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$13.89B
Return on Equity (ROE)
3.29%
TTM Avg
3.59%
3Y Avg
3.35%
5Y Avg
7.68%
Market Cap
$11.31B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$14.54B
Return on Equity (ROE)
46.68%
TTM Avg
29.72%
3Y Avg
22.87%
5Y Avg
17.28%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Baxter International Inc. (BAX) | $12.76B | -17.13% | -11.55% | 0.28% | -2.79% |
| The Cooper Companies, Inc. (COO)vs › | $12.61B | 2.86% | 4.70% | 4.67% | 11.22% |
| Penumbra, Inc. (PEN)vs › | $12.60B | 10.49% | 6.83% | 5.29% | 3.21% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.34B | -8.40% | -2.13% | 6.32% | 9.65% |
| Encompass Health Corporation (EHC)vs › | $12.02B | 23.91% | 22.63% | 21.83% | 21.13% |
| DaVita Inc. (DVA)vs › | $11.80B | N/A | 329.18% | 200.63% | 164.66% |
| Revvity, Inc. (RVTY)vs › | $13.89B | 3.29% | 3.59% | 3.35% | 7.68% |
| Bio-Techne Corporation (TECH)vs › | $11.31B | 8.63% | 6.23% | 8.78% | 10.01% |
| Exelixis, Inc. (EXEL)vs › | $14.54B | 46.68% | 29.72% | 22.87% | 17.28% |
| Align Technology, Inc. (ALGN)vs › | $10.90B | 9.77% | 10.54% | 10.84% | 19.93% |
ROE
-17.1%
ROA
-5.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -17.13% |
| 2026-03-31 | -18.17% |
| 2025-12-31 | -15.61% |
| 2025-09-30 | -4.71% |
| 2025-06-30 | -2.12% |
| 2025-03-31 | -7.91% |
| 2024-12-31 | -9.32% |
| 2024-09-30 | 1.37% |
| 2024-06-30 | 32.40% |
| 2024-03-31 | 32.41% |
| 2023-12-31 | 31.61% |
| 2023-09-30 | 32.00% |
| 2023-06-30 | -51.23% |
| 2023-03-31 | -41.84% |
| 2022-12-31 | -41.71% |
| 2022-09-30 | -42.93% |
| 2022-06-30 | 11.41% |
| 2022-03-31 | 11.65% |
| 2021-12-31 | 14.15% |
| 2021-09-30 | 13.84% |
| 2021-06-30 | 13.19% |
| 2021-03-31 | 12.64% |
| 2020-12-31 | 12.68% |
| 2020-09-30 | 10.63% |
| 2020-06-30 | 11.37% |
| 2020-03-31 | 12.87% |
| 2019-12-31 | 12.70% |
| 2019-09-30 | 18.08% |
| 2019-06-30 | 19.47% |
| 2019-03-31 | 20.29% |
| 2018-12-31 | 20.37% |
| 2018-09-30 | 12.91% |
| 2018-06-30 | 10.27% |
| 2018-03-31 | 9.17% |
| 2017-12-31 | 7.86% |
| 2017-09-30 | 10.89% |
| 2017-06-30 | 9.92% |
| 2017-03-31 | 21.38% |
| 2016-12-31 | 59.89% |
| 2016-09-30 | 56.78% |
| 2016-06-30 | 56.39% |
| 2016-03-31 | 43.44% |
| 2015-12-31 | 10.94% |
| 2015-09-30 | 21.93% |
| 2015-06-30 | 27.33% |
| 2015-03-31 | 32.67% |
| 2014-12-31 | 30.75% |
| 2014-09-30 | 22.25% |
| 2014-06-30 | 22.47% |
| 2014-03-31 | 23.25% |
| 2013-12-31 | 23.77% |
| 2013-09-30 | 28.13% |
| 2013-06-30 | 30.47% |
| 2013-03-31 | 32.90% |
| 2012-12-31 | 33.53% |
| 2012-09-30 | 32.19% |
| 2012-06-30 | 34.93% |
| 2012-03-31 | 33.34% |
| 2011-12-31 | 33.77% |
| 2011-09-30 | 31.42% |
| 2011-06-30 | 30.48% |
| 2011-03-31 | 30.49% |
| 2010-12-31 | 21.62% |
| 2010-09-30 | 24.02% |
| 2010-06-30 | 26.69% |
| 2010-03-31 | 25.29% |
| 2009-12-31 | 30.66% |
| 2009-09-30 | 31.08% |
| 2009-06-30 | 32.72% |
| 2009-03-31 | 34.45% |
| 2008-12-31 | 32.33% |
| 2008-09-30 | 27.24% |
| 2008-06-30 | 25.57% |
| 2008-03-31 | 24.77% |
| 2007-12-31 | 24.68% |
| 2007-09-30 | 26.38% |
| 2007-06-30 | 24.50% |
| 2007-03-31 | 22.97% |
| 2006-12-31 | 22.26% |
| 2006-09-30 | 19.83% |
| 2006-06-30 | 17.03% |
| 2006-03-31 | 17.61% |
| 2005-12-31 | 22.24% |
| 2005-09-30 | 17.60% |
| 2005-06-30 | 22.09% |
| 2005-03-31 | 10.92% |
| 2004-12-31 | 10.53% |
| 2004-09-30 | 17.77% |
| 2004-06-30 | 19.23% |
| 2004-03-31 | 23.76% |
| 2003-12-31 | 26.82% |
| 2003-09-30 | 14.91% |
| 2003-06-30 | 18.63% |
